THE INTERACTION OF 5-FLUOROURACIL, HYDROXYUREA, AND RADIATION IN 2 HUMAN HEAD AND NECK-CANCER CELL-LINES

被引:0
|
作者
VOKES, EE [1 ]
BECKETT, M [1 ]
KARRISON, T [1 ]
WEICHSELBAUM, RR [1 ]
机构
[1] UNIV CHICAGO, MED CTR, DEPT RADIAT & CELLULAR ONCOL, CHICAGO, IL 60637 USA
关键词
5-FLUOROURACIL; HYDROXYUREA; RADIATION; HEAD NECK CANCER CELL LINES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the effects of 5-fluorouracil (5-FU) and hydroxyurea (HU) with radiation on two human head and neck squamous carcinoma cell lines. SQ-20B has a D0 of 239 cGy and an S phase fraction of 37%, while SQ-38 has a D0 of 146 cGy and an S phase fraction of 31%. For SQ-20B the surviving fraction at 100 cGy was significantly reduced (p < 0.05) when cells were exposed to HU or to 5-FU or both chemotherapy agents together with radiation. No significant effect was seen for SQ-38 with either chemotherapy agent alone or in combination with radiation as compared with radiation alone. Therefore, additive cytotoxicity between 5-FU and HU and radiotherapy was observed only in a head and neck cancer cell line with a higher DO and a higher S phase fraction.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 50 条
  • [31] TOLERANCE OF EXTENDED (28-DAY) CONTINUOUS INFUSION OF 5-FLUOROURACIL IN ADVANCED HEAD AND NECK-CANCER
    GRUNBERG, SM
    CLAY, C
    SPICER, DV
    SELECTIVE CANCER THERAPEUTICS, 1991, 7 (01): : 17 - 21
  • [32] COMBINATION CYTOTOXIC EFFECTS OF 5-FLUOROURACIL AND CARBOPLATIN AGAINST HUMAN LUNG-CANCER CELL-LINES
    SATOH, H
    ISHIKAWA, H
    FUNAYAMA, Y
    YAZAWA, T
    OGATA, T
    HASEGAWA, S
    CANCER RESEARCH THERAPY & CONTROL, 1995, 4 (03): : 199 - 202
  • [33] THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL
    COPUR, S
    AIBA, K
    DRAKE, JC
    ALLEGRA, CJ
    CHU, E
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) : 1419 - 1426
  • [34] TREATMENT OF RECURRENT HEAD AND NECK-CANCER WITH CISPLATIN AND 5-FLUOROURACIL VS THE SAME PLUS BLEOMYCIN AND METHOTREXATE
    AMREIN, PC
    FABIAN, RL
    LARYNGOSCOPE, 1992, 102 (08): : 901 - 907
  • [35] 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID AS 2ND-LINE CHEMOTHERAPY IN HEAD AND NECK-CANCER
    MERLANO, M
    BACIGALUPO, A
    BENASSO, M
    GRIMALDI, A
    TOMA, S
    BENEDETTI, G
    COMELLA, G
    CACACE, F
    ROSSO, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 1 - 3
  • [36] RESPONSE TO PREOPERATIVE CONCOMITANT RADIOCHEMOTHERAPY WITH MITOMYCIN-C AND 5-FLUOROURACIL IN ADVANCED HEAD AND NECK-CANCER
    DOBROWSKY, W
    DOBROWSKY, E
    STRASSL, H
    BRAUN, O
    SCHEIBER, V
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05): : 845 - 849
  • [37] Phase 2 Trial of Concurrent 5-Fluorouracil, Hydroxyurea, Cetuximab, and Hyperfractionated Intensity-Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer
    Kao, Johnny
    Genden, Eric M.
    Gupta, Vishal
    Policarpio, Edelweiss L.
    Burri, Ryan J.
    Rivera, Michael
    Gurudutt, Vivek
    Som, Peter M.
    Teng, Marita
    Packer, Stuart H.
    CANCER, 2011, 117 (02) : 318 - 326
  • [38] ALTERNATING CISPLATIN-5-FLUOROURACIL AND RADIOTHERAPY IN HEAD AND NECK-CANCER
    MERLANO, M
    GRIMALDI, A
    BENASSO, M
    BACIGALUPO, A
    TOMA, S
    SCARPATI, D
    CORVO, R
    SANTELLI, A
    GARAVENTA, G
    ROSSO, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 538 - 542
  • [39] MODIFIED 5-FLUOROURACIL (5FU)+ CISPLATINUM (CP) REGIMEN IN ADVANCED SQUAMOUS HEAD AND NECK-CANCER (HNC)
    KRASNOW, SH
    WADLEIGH, RG
    ANDERSON, AJ
    WHITE, KS
    COHEN, MH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 216 - 216
  • [40] Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer
    Haraf, DJ
    Stenson, K
    List, M
    Witt, ME
    Weichselbaum, RR
    Vokes, EE
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S68 - S71